Similar articles

• Murine cardiac allograft survival following treatment of recipients with monoclonal anti-L3T4 or Ly-2 antibodies.

  Mottram PL, Wheelahan J, McKenzie IF, Clunie GJ. Mottram PL, et al. Transplant Proc. 1987 Apr;19(2):2898-901. Transplant Proc. 1987. PMID: 3105127 No abstract available.
• Effect of L3T4 and Lyt-2 monoclonal antibodies on islet xenograft (rat to mouse) rejection.

  Kawai M, Gotoh M, Monden M, Yamamoto H, Ichikawa T, Valdivia LA, Mori T, Uenaka A, Nakayama E. Kawai M, et al. Transplant Proc. 1989 Feb;21(1 Pt 3):2709-10. Transplant Proc. 1989. PMID: 2495677 No abstract available.
• The effect of anti-L3T4 monoclonal antibody treatment on first-set rejection of murine cardiac allografts.

  Madsen JC, Peugh WN, Wood KJ, Morris PJ. Madsen JC, et al. Transplantation. 1987 Dec;44(6):849-52. Transplantation. 1987. PMID: 3321596 No abstract available.
• Role of accessory molecules in signal transduction of cytolytic T lymphocyte by anti-T cell receptor and anti-Ly-6.2C monoclonal antibodies.

  Leo O, Foo M, Henkart PA, Perez P, Shinohara N, Segal DM, Bluestone JA. Leo O, et al. J Immunol. 1987 Dec 1;139(11):3556-63. J Immunol. 1987. PMID: 3316387
• Monoclonal antibodies for the depletion of specific subpopulations of lymphocytes.

  Waldmann H, Cobbold S, Qin S, Benjamin R, Nash T, Welsh J, Tarnesby G. Waldmann H, et al. Ciba Found Symp. 1987;129:194-208. doi: 10.1002/9780470513484.ch13. Ciba Found Symp. 1987. PMID: 3315502 Review.